{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:13:23Z","timestamp":1790241203014,"version":"4.1.0"},"reference-count":324,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by immune-mediated destruction of pancreatic \u03b2-cells, resulting in absolute insulin deficiency and lifelong dependence on exogenous insulin therapy. As a chronic condition with substantial population-level clinical, psychosocial, and economic consequences, T1D represents an important public health challenge that extends beyond individual glycemic management. Although major advances in insulin formulations, continuous glucose monitoring systems, and automated insulin delivery technologies have substantially improved glycemic control and reduced complications, these approaches remain fundamentally disease-management strategies and do not address the underlying autoimmune pathology or restore durable endogenous insulin secretion. Over the past several decades, multiple clinical trials targeting immune modulation, \u03b2-cell preservation, transplantation, and metabolic pathways have generated significant mechanistic insights but have rarely achieved sustained insulin independence or long-term disease remission. Progress toward disease-modifying and prevention-oriented therapies has been hindered by biological heterogeneity, limited mechanistic biomarkers, translational gaps between experimental models and human disease, and fragmented data ecosystems. Advances in artificial intelligence (AI) and machine learning (ML) enable integrative analysis of multi-omics, clinical, and digital health datasets to define disease endotypes, predict disease trajectories, and guide the rational design of combination therapies and adaptive clinical trials. Within a digital public health framework, these approaches may also support earlier risk stratification, improved therapeutic targeting, more efficient trial design, and scalable implementation across diverse populations. However, the clinical translation of AI in T1D remains constrained by heterogeneity and fragmentation across available datasets, limited external validation, and inadequate representation of demographically and clinically diverse populations. Additional barriers include data privacy and governance requirements, the risk of algorithmic bias, and the need for interpretable and reproducible AI models that can meet rigorous clinical, ethical, and regulatory standards. This review synthesizes current knowledge of T1D pathophysiology and critically examines historical limitations in therapeutic development while proposing an AI-enabled precision medicine framework that integrates immune tolerance induction, \u03b2-cell restoration strategies, and metabolic optimization. Finally, we outline a translational roadmap for data-driven therapeutic discovery and adaptive clinical development aimed at accelerating progress toward durable, scalable, equitable, and biologically informed interventions for T1D with relevance to public health practice, prevention, and population health outcomes.<\/jats:p>","DOI":"10.3389\/fpubh.2026.1915502","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:56:17Z","timestamp":1790240177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence-driven therapeutics for disease modification in type 1 diabetes: a digital public health and clinical translation framework"],"prefix":"10.3389","volume":"14","author":[{"given":"Krish","family":"Hirani","sequence":"first","affiliation":[{"name":"Diabetes Research Institute, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Blaschke","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Olloqui","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mittal","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/dom.16628","article-title":"The pathophysiology, presentation and classification of type 1 diabetes","volume":"27","author":"Aamodt","year":"2025","journal-title":"Diabetes Obes Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1002\/edm2.70119","article-title":"Type 1 diabetes and other autoimmune diseases-epidemiology, pathophysiology and screening","volume":"9","author":"Kahaly","year":"2026","journal-title":"Endocrinol Diabetes Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1335435","DOI":"10.3389\/fendo.2024.1335435","article-title":"Gene-environment interaction in the pathophysiology of type 1 diabetes","volume":"15","author":"Mittal","year":"2024","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2024.06.029","article-title":"Diabetes mellitus-progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"112277","DOI":"10.1016\/j.diabres.2025.112277","article-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the international diabetes federation atlas, 11th edition, and the T1D index version 3.0","volume":"225","author":"Ogle","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41390-024-03107-5","article-title":"Global, regional, and national burden of type 1 diabetes in adolescents and young adults","volume":"97","author":"Gong","year":"2025","journal-title":"Pediatr Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e44419","DOI":"10.1097\/MD.0000000000044419","article-title":"Global burden of type 1 diabetes mellitus in women of childbearing age from 1990 to 2021 with projections to 2030","volume":"104","author":"Liu","year":"2025","journal-title":"Medicine."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1596127","DOI":"10.3389\/fendo.2025.1596127","article-title":"Global burden of diabetes mellitus 1990\u20132021: epidemiological trends, geospatial disparities, and risk factor dynamics","volume":"16","author":"Pan","year":"2025","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70133","DOI":"10.1111\/dme.70133","article-title":"A longitudinal cohort study describing childhood type 1 diabetes incidence and prevalence rates in British Columbia, Canada over 27 years (1997\u20132023)","volume":"42","author":"Amed","year":"2025","journal-title":"Diabet Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","article-title":"100 years of insulin: celebrating the past, present and future of diabetes therapy","volume":"27","author":"Sims","year":"2021","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e240258","DOI":"10.20945\/2359-4292-2024-0258","article-title":"Diabetic retinopathy and diabetic kidney disease, either isolated or associated, impact on the 10-year risk of cardiovascular disease: are we dealing with similar conditions?","volume":"69","author":"Maraschin","year":"2025","journal-title":"Arch Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0298457","DOI":"10.1371\/journal.pone.0298457","article-title":"A systematic review of the association of type I diabetes with sensorineural hearing loss","volume":"19","author":"Mittal","year":"2024","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0308556","DOI":"10.1371\/journal.pone.0308556","article-title":"Systematic review of translational insights: neuromodulation in animal models for diabetic peripheral neuropathy","volume":"19","author":"Mittal","year":"2024","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103232","DOI":"10.1016\/j.eclinm.2025.103232","article-title":"Familial clustering of diabetic kidney disease and retinopathy in offspring of parents with type 1 diabetes: a population-based study","volume":"83","author":"Herrlin","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00125-025-06438-y","article-title":"Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring","volume":"68","author":"Eeg-Olofsson","year":"2025","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/dia.2024.0404","article-title":"The virtual DCCT: adding continuous glucose monitoring to a landmark clinical trial for prediction of microvascular complications","volume":"27","author":"Kovatchev","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-161250","article-title":"Type 1 diabetes mellitus and cognitive impairments: a systematic review","volume":"57","author":"Li","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-981-15-1792-1_7","article-title":"Exercise and type 1 diabetes","volume":"1228","author":"Lu","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2337\/dc25-0559","article-title":"Diabetes-related distress and glycemic dysregulation in everyday life with type 1 diabetes: which comes first?","volume":"48","author":"Gonzalez","year":"2025","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.hctj.2025.100101","article-title":"Quality of life in young adults with type 1 diabetes","volume":"3","author":"Baudino","year":"2025","journal-title":"Health Care Transit"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251400209","article-title":"Variation in hypoglycemia risk during real-world physical activity in adults with type 1 diabetes: insights from the type 1 diabetes exercise initiative","author":"Dhaliwal","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/db24-1122","article-title":"Autoreactive T cells and cytokine stress drive \u03b2-cell senescence entry and accumulation in type 1 diabetes","volume":"74","author":"Pipella","year":"2025","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1599321","DOI":"10.3389\/fimmu.2025.1599321","article-title":"Interplay of hypoxia, immune dysregulation, and metabolic stress in pathophysiology of type 1 diabetes","volume":"16","author":"Mittal","year":"2025","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00008.2025","article-title":"Molecular and inflammatory etiologies of \u03b2-cell dysfunction in type 1 diabetes","volume":"40","author":"Rostron","year":"2025","journal-title":"Physiology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MED.0000000000000548","article-title":"The role of beta-cell dysfunction in early type 1 diabetes","volume":"27","author":"Sims","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00125-025-06382-x","article-title":"IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes","volume":"68","author":"Sims","year":"2025","journal-title":"Diabetologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00125-025-06455-x","article-title":"A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population","volume":"68","author":"Hu","year":"2025","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e42156","DOI":"10.1016\/j.heliyon.2025.e42156","article-title":"The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progression","volume":"11","author":"Vandewalle","year":"2025","journal-title":"Heliyon"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3346256","DOI":"10.1155\/jdr\/3346256","article-title":"Exome sequencing of a type 1 diabetes mellitus family exposes both common and individualized rare variants contributing to pathogenesis","volume":"2025","author":"Ibrahim","year":"2025","journal-title":"J Diabetes Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11033-025-10404-7","article-title":"MALAT1 SNP (rs619586) shows a protective effect against type 1 diabetes mellitus, while the miR-146a SNP (rs57095329) is linked to an increased risk of developing the disease","volume":"52","author":"Hamdy","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2337\/db25-0067","article-title":"Genome-wide aggregated trans effects analysis for circulating proteins indicates a key role of immune checkpoints in type 1 diabetes","volume":"74","author":"Zhou","year":"2025","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12916-025-04527-8","article-title":"Immune cell-based transcriptomic Mendelian randomization and colocalization study on type 1 diabetes","volume":"23","author":"Sklar","year":"2025","journal-title":"BMC Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.ebiom.2025.105932","article-title":"The type 1 diabetes candidate genes PTPN2 and BACH2 regulate the IFN-\u03b1-induced crosstalk between JAK\/STAT and MAPKs pathways in human beta cells","volume":"120","author":"Roca-Rivada","year":"2025","journal-title":"EBioMedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2337\/db25-0805","article-title":"Distinct enterovirus antigen landscape in children with islet autoimmunity","volume":"75","author":"Delgado-Corrales","year":"2026","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2337\/db25-0156","article-title":"Serum metabolomics reveals potential differences in gut microbiota-associated metabolites in twins discordant for type 1 diabetes","volume":"74","author":"Flammer","year":"2025","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e70076","DOI":"10.1002\/dmrr.70076","article-title":"Alternations of gut microbiome and serum metabolome with prolongation of the course of type 1 diabetes mellitus","volume":"41","author":"Li","year":"2025","journal-title":"Diabetes Metab Res Rev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00125-025-06635-9","article-title":"Dietary intake of vitamins A, B, C, D and E and risk of islet autoimmunity and type 1 diabetes in genetically at-risk children: a prospective study from the DIPP birth cohort","volume":"69","author":"Mattila","year":"2026","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1529447","DOI":"10.3389\/fendo.2025.1529447","article-title":"Infections and antibiotic use in early childhood have limited importance in developing manifest type 1 diabetes - the ABIS cohort study","volume":"16","author":"B\u00e9lteky","year":"2025","journal-title":"Front Endocrinol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.2337\/dc25-0330","article-title":"DNA methylation smoking scores and risk of islet autoimmunity and type 1 diabetes","volume":"48","author":"Vanderlinden","year":"2025","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1744422","DOI":"10.3389\/fimmu.2026.1744422","article-title":"Neoepitopes at the crossroads of immunometabolism: metabolic remodeling of antigen presentation in type 1 diabetes","volume":"17","author":"Mittal","year":"2026","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1678047","DOI":"10.3389\/fdgth.2025.1678047","article-title":"Federated multimodal AI for precision-equitable diabetes care","volume":"7","author":"Bai","year":"2025","journal-title":"Front Digit Health."},{"key":"B43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s40200-025-01648-y","article-title":"Revolutionizing diabetes care: the role of artificial intelligence in prevention, diagnosis, and patient care","volume":"24","author":"Kohli","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/ijms27020802","article-title":"Artificial intelligence-driven transformation of pediatric diabetes care: a systematic review and epistemic meta-analysis of diagnostic, therapeutic, and self-management applications","volume":"27","author":"Valdespino-Salda\u00f1a","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e70002","DOI":"10.1002\/qub2.70002","article-title":"Revolutionizing multi-omics analysis with artificial intelligence and data processing","volume":"13","author":"Yetgin","year":"2025","journal-title":"Quant Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/15578100251392371","article-title":"Deepika, Roy S. Integrative multi-omics and artificial intelligence: a new paradigm for systems biology","volume":"29","author":"Kant","year":"2025","journal-title":"Omics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000542002","article-title":"Immunotherapy-based strategies for treatment of type 1 diabetes","volume":"98","author":"Jacobsen","year":"2025","journal-title":"Horm Res Paediatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s13340-024-00748-z","article-title":"Type 1 diabetes: immune pathology and novel therapeutic approaches","volume":"15","author":"Ling","year":"2024","journal-title":"Diabetol Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1159\/000524866","article-title":"Recent advances in immune-based therapies for type 1 diabetes","volume":"96","author":"Smigoc Schweiger","year":"2023","journal-title":"Horm Res Paediatr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.molmet.2023.101809","article-title":"The beta cell-immune cell interface in type 1 diabetes (T1D)","volume":"78","author":"James","year":"2023","journal-title":"Mol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/ITT.S417917","article-title":"Exploration of immune targets for type 1 diabetes and latent autoimmune disease immunotherapy","volume":"12","author":"Siddiqui","year":"2023","journal-title":"Immunotargets Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1450366","DOI":"10.3389\/fimmu.2024.1450366","article-title":"The role of B cells in the pathogenesis of type 1 diabetes","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","article-title":"The immunology of type 1 diabetes","volume":"24","author":"Herold","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1111\/dom.15581","article-title":"Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: an updated systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Grando Alves","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e161812","DOI":"10.1172\/jci.insight.161812","article-title":"Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes","volume":"8","author":"Jacobsen","year":"2023","journal-title":"JCI Insight"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e177492","DOI":"10.1172\/JCI177492","article-title":"Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes","volume":"134","author":"Lled\u00f3-Delgado","year":"2024","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/1744666X.2023.2281990","article-title":"Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function","volume":"20","author":"Fanaropoulou","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"a041623","DOI":"10.1101\/cshperspect.a041623","article-title":"The pathogenesis of type 1 diabetes","volume":"15","author":"Herold","year":"2025","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-023-05970-z","article-title":"Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell","volume":"66","author":"Thompson","year":"2023","journal-title":"Diabetologia"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00125-023-05927-2","article-title":"The countdown to type 1 diabetes: when, how and why does the clock start?","volume":"66","author":"Ziegler","year":"2023","journal-title":"Diabetologia."},{"key":"B61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41574-023-00826-3","article-title":"Why does the immune system destroy pancreatic \u03b2-cells but not \u03b1-cells in type 1 diabetes?","volume":"19","author":"Eizirik","year":"2023","journal-title":"Nat Rev Endocrinol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1386471","DOI":"10.3389\/fendo.2024.1386471","article-title":"Endoplasmic reticulum stress in pancreatic \u03b2-cell dysfunctionality and diabetes mellitus: a promising target for generation of functional hPSC-derived \u03b2-cells in vitro","volume":"15","author":"Diane","year":"2024","journal-title":"Front Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/biology13060379","article-title":"Disrupted endoplasmic reticulum Ca(2+) handling: a har\u03b2inger of \u03b2-cell failure","volume":"13","author":"Dobson","year":"2024","journal-title":"Biology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1618086","DOI":"10.3389\/fimmu.2025.1618086","article-title":"Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling","volume":"16","author":"Karaoglu","year":"2025","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"101998","DOI":"10.1016\/j.molmet.2024.101998","article-title":"Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes","volume":"88","author":"Roy","year":"2024","journal-title":"Mol Metab."},{"key":"B66","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvae002","article-title":"Insulitis in human type 1 diabetes: lessons from an enigmatic lesion","volume":"190","author":"Morgan","year":"2024","journal-title":"Eur J Endocrinol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41574-024-01029-0","article-title":"Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead","volume":"21","author":"Grattoni","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2337\/dci25-0066","article-title":"Toward disease-modifying therapies in type 1 diabetes: focus on teplizumab","volume":"49","author":"Mathieu","year":"2026","journal-title":"Diabetes Care"},{"key":"B69","doi-asserted-by":"publisher","first-page":"14565","DOI":"10.3389\/ti.2025.14565","article-title":"The last mile in beta-cell replacement therapy for type 1 diabetes: time to grow up","volume":"38","author":"Piemonti","year":"2025","journal-title":"Transpl Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00592-025-02478-3","article-title":"Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes","volume":"62","author":"Syed Khaja","year":"2025","journal-title":"Acta Diabetol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1740102","DOI":"10.3389\/fendo.2025.1740102","article-title":"Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/biom15030441","article-title":"Tissue resident and infiltrating immune cells: their influence on the demise of beta cells in type 1 diabetes","volume":"15","author":"Walker","year":"2025","journal-title":"Biomolecules"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2337\/dci25-0013","article-title":"The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 diabetes, diabetes care, and diabetologia expert forum","volume":"48","author":"Evans-Molina","year":"2025","journal-title":"Diabetes Care"},{"key":"B74","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/dc24-1251","article-title":"Genetic discovery and risk prediction for type 1 diabetes in individuals without high-risk HLA-DR3\/DR4 haplotypes","volume":"48","author":"McGrail","year":"2025","journal-title":"Diabetes Care"},{"key":"B75","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00125-024-06338-7","article-title":"Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes","volume":"68","author":"Redondo","year":"2025","journal-title":"Diabetologia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00125-025-06613-1","article-title":"Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity","volume":"69","author":"Veijola","year":"2026","journal-title":"Diabetologia"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e70103","DOI":"10.1002\/dmrr.70103","article-title":"The role of HLA class II two-locus haplotypes and genotypes in chinese with type 1 diabetes","volume":"41","author":"Liu","year":"2025","journal-title":"Diabetes Metab Res Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1172\/jci.insight.184348","article-title":"Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers","author":"Zhao","year":"2025","journal-title":"JCI Insight"},{"key":"B79","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00125-024-06323-0","article-title":"Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab","volume":"68","author":"Galderisi","year":"2025","journal-title":"Diabetologia"},{"key":"B80","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jama.2023.9113","article-title":"Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial","volume":"329","author":"Forlenza","year":"2023","journal-title":"JAMA"},{"key":"B81","doi-asserted-by":"crossref","DOI":"10.3310\/FQLN7416","volume-title":"The Efficacy and Safety of Ustekinumab in Adolescents Newly Diagnosed with Type 1 Diabetes: The USTEK1D RCT","author":"Carter","year":"2025"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00125-023-06003-5","article-title":"High proinsulin: C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment","volume":"66","author":"Sims","year":"2023","journal-title":"Diabetologia"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00125-024-06213-5","article-title":"Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes","volume":"67","author":"de Wit","year":"2024","journal-title":"Diabetologia"},{"key":"B84","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/nu16020199","article-title":"Sensor-based glucose metrics during different diet compositions in type 1 diabetes-a randomized one-week crossover trial","volume":"16","author":"Kristensen","year":"2024","journal-title":"Nutrients"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1249\/MSS.0000000000003720","article-title":"Acute effects of daily life spontaneous and structured physical activity on glycemia in children with type 1 diabetes","volume":"57","author":"Melin","year":"2025","journal-title":"Med Sci Sports Exerc"},{"key":"B86","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/clinem\/dgae451","article-title":"Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes","volume":"110","author":"Hormaz\u00e1bal-Aguayo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e082453","DOI":"10.1136\/bmjopen-2023-082453","article-title":"Cohort profile: the \u2018Biomarkers of heterogeneity in type 1 diabetes' study-a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands","volume":"14","author":"Aanstoot","year":"2024","journal-title":"BMJ Open"},{"key":"B88","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1038\/s41467-023-42581-z","article-title":"A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes","volume":"14","author":"Ylescupidez","year":"2023","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"a041587","DOI":"10.1101\/cshperspect.a041587","article-title":"Advancing animal models of human type 1 diabetes","volume":"14","author":"Serreze","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1425235","DOI":"10.3389\/fendo.2024.1425235","article-title":"The protective effect of the intestinal microbiota in type-1 diabetes in NOD mice is limited to a time window in early life","volume":"15","author":"Fernandez Trigo","year":"2024","journal-title":"Front Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2337\/db23-0709","article-title":"Type 1 Diabetes depends on CD4-driven expression of the transcriptional repressor Bcl6","volume":"74","author":"McNitt","year":"2025","journal-title":"Diabetes"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.2337\/db23-1000","article-title":"Role of peptidyl arginine deiminase 4-dependent macrophage extracellular trap formation in type 1 diabetes pathogenesis","volume":"73","author":"Shen","year":"2024","journal-title":"Diabetes"},{"key":"B93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","article-title":"An autoimmune stem-like CD8 T cell population drives type 1 diabetes","volume":"602","author":"Gearty","year":"2022","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41590-020-0633-5","article-title":"Beta cell-specific CD8(+) T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes","volume":"21","author":"Abdelsamed","year":"2020","journal-title":"Nat Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"9204","DOI":"10.1038\/s41467-024-53255-9","article-title":"Physiological and pathogenic T cell autoreactivity converge in type 1 diabetes","volume":"15","author":"Eugster","year":"2024","journal-title":"Nat Commun"},{"key":"B96","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2337\/db25-0241","article-title":"B lymphocytes impede tregs to erode islet tolerance in type 1 diabetes","volume":"75","author":"Wilson","year":"2026","journal-title":"Diabetes"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2337\/db22-0177","article-title":"Soluble RAGE prevents type 1 diabetes expanding functional regulatory t cells","volume":"71","author":"Leung","year":"2022","journal-title":"Diabetes"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1695894","DOI":"10.3389\/fimmu.2025.1695894","article-title":"The role of microRNAs and long non-coding RNAs in epigenetic regulation of T cells: implications for autoimmunity","volume":"16","author":"Prasad","year":"2025","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"eadj6975","DOI":"10.1126\/sciadv.adj6975","article-title":"Tracking DNA-based antigen-specific T cell receptors during progression to type 1 diabetes","volume":"9","author":"Mitchell","year":"2023","journal-title":"Sci Adv"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.2337\/db21-0091","article-title":"Reduced follicular regulatory T Cells in spleen and pancreatic lymph nodes of patients with type 1 diabetes","volume":"70","author":"Vecchione","year":"2021","journal-title":"Diabetes"},{"key":"B101","doi-asserted-by":"publisher","first-page":"eadn2404","DOI":"10.1126\/scitranslmed.adn2404","article-title":"A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes","volume":"16","author":"Bender","year":"2024","journal-title":"Sci Transl Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/db25-0161","article-title":"Memory regulatory T cells as a biomarker of early type 1 diabetes","volume":"75","author":"Raineri","year":"2026","journal-title":"Diabetes"},{"key":"B103","doi-asserted-by":"publisher","first-page":"11301","DOI":"10.1038\/s41467-025-66459-4","article-title":"Imbalance of stem-like and effector T cell states in children with early type 1 diabetes across conventional and regulatory subsets","volume":"16","author":"Niederlova","year":"2025","journal-title":"Nat Commun"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1038\/s41467-022-32425-7","article-title":"Adaptation to chronic ER stress enforces pancreatic \u03b2-cell plasticity","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.cmet.2023.10.014","article-title":"Stress-induced \u03b2 cell early senescence confers protection against type 1 diabetes","volume":"35","author":"Lee","year":"2023","journal-title":"Cell Metab"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1038\/s41467-020-16327-0","article-title":"An integrated multi-omics approach identifies the landscape of interferon-\u03b1-mediated responses of human pancreatic beta cells","volume":"11","author":"Colli","year":"2020","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41467-025-55908-9","article-title":"Interferon-\u03b1 promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic \u03b2-cells","volume":"16","author":"Carr\u00e9","year":"2025","journal-title":"Nat Commun"},{"key":"B108","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1038\/s41467-022-34069-z","article-title":"The type 1 diabetes gene TYK2 regulates \u03b2-cell development and its responses to interferon-\u03b1","volume":"13","author":"Chandra","year":"2022","journal-title":"Nat Commun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/db21-0443","article-title":"PTPN2 regulates the interferon signaling and endoplasmic reticulum stress response in pancreatic \u03b2-cells in autoimmune diabetes","volume":"71","author":"Elvira","year":"2022","journal-title":"Diabetes"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1007\/s00125-024-06192-7","article-title":"Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study","volume":"67","author":"Vatanen","year":"2024","journal-title":"Diabetologia"},{"key":"B111","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41467-025-67712-6","article-title":"The inflammatory path toward type 1 diabetes begins during pregnancy","volume":"17","author":"Ahrens","year":"2026","journal-title":"Nat Commun"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e3833","DOI":"10.1002\/dmrr.3833","article-title":"Multi-omics analysis reveals drivers of loss of \u03b2-cell function after newly diagnosed autoimmune type 1 diabetes: an INNODIA multicenter study","volume":"40","author":"Armenteros","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"B114","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","article-title":"Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes","volume":"4","author":"Fasolino","year":"2022","journal-title":"Nat Metab"},{"key":"B115","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","article-title":"Interferons are key cytokines acting on pancreatic islets in type 1 diabetes","volume":"67","author":"Coomans de Brach\u00e8ne","year":"2024","journal-title":"Diabetologia."},{"key":"B116","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s42255-020-0254-1","article-title":"Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes","volume":"2","author":"Cai","year":"2020","journal-title":"Nat Metab"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/biom12101444","article-title":"Exploring computational data amplification and imputation for the discovery of type 1 diabetes (T1D) biomarkers from limited human datasets","volume":"12","author":"Alcazar","year":"2022","journal-title":"Biomolecules"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.3390\/ijms26093935","article-title":"Harnessing machine learning, a subset of artificial intelligence, for early detection and diagnosis of type 1 diabetes: a systematic review","volume":"26","author":"Mittal","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1142648","DOI":"10.3389\/fimmu.2023.1142648","article-title":"Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8(+) T cells","volume":"14","author":"Peters","year":"2023","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41431-018-0123-5","article-title":"Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes","volume":"26","author":"Ge","year":"2018","journal-title":"Eur J Hum Genet."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e1004404","DOI":"10.1371\/journal.pgen.1004404","article-title":"Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells","volume":"10","author":"Hu","year":"2014","journal-title":"PLoS Genet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-024-01300-z","article-title":"Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes","volume":"16","author":"Honardoost","year":"2024","journal-title":"Genome Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s43856-025-00922-7","article-title":"A multi-omics integration approach relying on circulating factors does not discern subtypes of childhood type 1 diabetes","volume":"5","author":"Codazzi","year":"2025","journal-title":"Commun Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"101535","DOI":"10.1016\/j.xcrm.2024.101535","article-title":"Modeling type 1 diabetes progression using machine learning and single-cell transcriptomic measurements in human islets","volume":"5","author":"Patil","year":"2024","journal-title":"Cell Rep Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2589-7500(24)00050-5","article-title":"Predicting type 1 diabetes in children using electronic health records in primary care in the UK: development and validation of a machine-learning algorithm","volume":"6","author":"Daniel","year":"2024","journal-title":"Lancet Digit Health"},{"key":"B128","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/19322968231209302","article-title":"Predicting the risk of developing type 1 diabetes using a one-week continuous glucose monitoring home test with classification enhanced by machine learning: an exploratory study","volume":"18","author":"Montaser","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2025.05.385","article-title":"Integration of multi-omics data and machine learning to identify antioxidant biomarkers in type 1 diabetes","volume":"236","author":"Luo","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"eady0080","DOI":"10.1126\/sciadv.ady0080","article-title":"Single-cell multiome and spatial profiling reveals pancreas cell type-specific gene regulatory programs of type 1 diabetes progression","volume":"11","author":"Melton","year":"2025","journal-title":"Sci Adv"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e70026","DOI":"10.1111\/1753-0407.70026","article-title":"\u03b2-Cell gene expression stress signatures in types 1 and 2 diabetes","volume":"16","author":"Yi","year":"2024","journal-title":"J Diabetes."},{"key":"B132","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-\u03b1 mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"B133","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00592-025-02607-y","article-title":"Mitochondrial dysfunction in type 1 diabetes and its implications for pancreatic beta-cell survival and insulin secretion","volume":"63","author":"Singh","year":"2025","journal-title":"Acta Diabetol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3390\/cells14231861","article-title":"\u03b2-cell mitochondrial dysfunction: underlying mechanisms and potential therapeutic strategies","volume":"14","author":"Darwish","year":"2025","journal-title":"Cells"},{"key":"B135","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.3390\/ijms23094843","article-title":"Endoplasmic reticulum (ER) stress and its role in pancreatic \u03b2-cell dysfunction and senescence in type 2 diabetes","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1211015","DOI":"10.3389\/fendo.2023.1211015","article-title":"Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children","volume":"14","author":"Lamichhane","year":"2023","journal-title":"Front Endocrinol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12016-025-09084-9","article-title":"Islet tissue macrophages in immunity homeostasis and type 1 diabetes","volume":"68","author":"Wang","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B140","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","article-title":"Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review","volume":"22","author":"Binuya","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-023-02858-y","article-title":"Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges","volume":"21","author":"Rahnenf\u00fchrer","year":"2023","journal-title":"BMC Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-statistics-042424-113016","article-title":"Integrative analysis of multimodal omics data","volume":"13","author":"Li","year":"2026","journal-title":"Annu Rev Stat Appl."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jamia\/ocae088","article-title":"Development and external validation of deep learning clinical prediction models using variable-length time series data","volume":"31","author":"Bashiri","year":"2024","journal-title":"J Am Med Inform Assoc."},{"key":"B144","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/hcs2.114","article-title":"Toward real-world deployment of machine learning for health care: External validation, continual monitoring, and randomized clinical trials","volume":"3","author":"Yuan","year":"2024","journal-title":"Health Care Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1109\/JBHI.2024.3393719","article-title":"Evaluating explanations from AI algorithms for clinical decision-making: a social science-based approach","volume":"28","author":"Ghanvatkar","year":"2024","journal-title":"IEEE J Biomed Health Inform."},{"key":"B146","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.csbj.2024.08.005","article-title":"Unveiling the black box: a systematic review of explainable artificial intelligence in medical image analysis","volume":"24","author":"Muhammad","year":"2024","journal-title":"Comput Struct Biotechnol J."},{"key":"B147","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.drudis.2024.103992","article-title":"Unleashing the power of generative AI in drug discovery","volume":"29","author":"Gangwal","year":"2024","journal-title":"Drug Discov Today."},{"key":"B148","doi-asserted-by":"publisher","first-page":"bbae338","DOI":"10.1093\/bib\/bbae338","article-title":"A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation","volume":"25","author":"Tang","year":"2024","journal-title":"Brief Bioinform"},{"key":"B149","doi-asserted-by":"publisher","first-page":"101006","DOI":"10.1016\/j.patter.2024.101006","article-title":"Recent methodological advances in federated learning for healthcare","volume":"5","author":"Zhang","year":"2024","journal-title":"Patterns"},{"key":"B150","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.patter.2024.100974","article-title":"Privacy preservation for federated learning in health care","volume":"5","author":"Pati","year":"2024","journal-title":"Patterns"},{"key":"B151","doi-asserted-by":"publisher","first-page":"111387","DOI":"10.1016\/j.jclinepi.2024.111387","article-title":"Don't be misled: 3 misconceptions about external validation of clinical prediction models","volume":"172","author":"la Roi-Teeuw","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e074820","DOI":"10.1136\/bmj-2023-074820","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"B153","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2337\/db23-0568","article-title":"Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice","volume":"73","author":"Kasinathan","year":"2024","journal-title":"Diabetes"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1474453","DOI":"10.3389\/fimmu.2024.1474453","article-title":"Insulin-degrading enzyme regulates insulin-directed cellular autoimmunity in murine type 1 diabetes","volume":"15","author":"Bessard","year":"2024","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1021\/acs.jproteome.1c00842","article-title":"HLA allele-specific quantitative profiling of type 1 diabetic B lymphocyte immunopeptidome","volume":"21","author":"Sudhir","year":"2022","journal-title":"J Proteome Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"115425","DOI":"10.1016\/j.celrep.2025.115425","article-title":"Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes","volume":"44","author":"Nicholas","year":"2025","journal-title":"Cell Rep"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4049\/jimmunol.2300785","article-title":"Altering \u03b2 cell antigen exposure to exhausted CD8+ T Cells prevents autoimmune diabetes in mice","volume":"212","author":"De George","year":"2024","journal-title":"J Immunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12860-023-00476-3","article-title":"Pre-treatment with IL-6 potentiates \u03b2-cell death induced by pro-inflammatory cytokines","volume":"24","author":"Oliveira","year":"2023","journal-title":"BMC Mol Cell Biol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"103414","DOI":"10.1016\/j.autrev.2023.103414","article-title":"Islet beta-cells and intercellular adhesion molecule-1 (ICAM-1): integrating immune responses that influence autoimmunity and graft rejection","volume":"22","author":"Martin","year":"2023","journal-title":"Autoimmun Rev."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2337\/dci23-0050","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial","volume":"46","author":"Russell","year":"2023","journal-title":"Diabetes Care"},{"key":"B161","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos","year":"2023","journal-title":"N Engl J Med"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N Engl J Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2337\/dc22-0908","article-title":"Two-year follow-up from the T1GER study: continued off-therapy metabolic improvements in children and young adults with new-onset T1D treated with golimumab and characterization of responders","volume":"46","author":"Rigby","year":"2023","journal-title":"Diabetes Care"},{"key":"B164","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S2213-8587(21)00139-X","article-title":"Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Gitelman","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2337\/db20-1103","article-title":"Low-dose ATG\/GCSF in established type 1 diabetes: a five-year follow-up report","volume":"70","author":"Lin","year":"2021","journal-title":"Diabetes"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e0323642","DOI":"10.1371\/journal.pone.0323642","article-title":"Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: a systematic review","volume":"20","author":"Mittal","year":"2025","journal-title":"PLoS ONE"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Low-dose anti-thymocyte globulin (ATG) preserves \u03b2-cell function and improves HbA(1c) in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00125-025-06646-6","article-title":"Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes","volume":"69","author":"Karakus","year":"2026","journal-title":"Diabetologia"},{"key":"B169","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2337\/dc25-1444","article-title":"Use of teplizumab to modulate stage 2 type 1 diabetes in two individuals with autoimmune polyendocrine syndrome 1","volume":"49","author":"Wilson","year":"2026","journal-title":"Diabetes Care"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/dom.14723","article-title":"Combined therapy with CD4(+) CD25highCD127(-) T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: randomized phase I\/II trial","volume":"24","author":"Zieli\u0144ski","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B171","doi-asserted-by":"publisher","first-page":"111919","DOI":"10.1016\/j.intimp.2024.111919","article-title":"PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration","volume":"132","author":"Zieli\u0144ski","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1112570","DOI":"10.3389\/fimmu.2023.1112570","article-title":"Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype","volume":"14","author":"Puente-Marin","year":"2023","journal-title":"Front Immunol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"797172","DOI":"10.3389\/fimmu.2021.797172","article-title":"Intralymphatic GAD-alum injection modulates B cell response and induces follicular helper T cells and PD-1+ CD8+ T cells in patients with recent-onset type 1 diabetes","volume":"12","author":"Barcenilla","year":"2021","journal-title":"Front Immunol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"103051","DOI":"10.1016\/j.jaut.2023.103051","article-title":"Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases","volume":"138","author":"Passeri","year":"2023","journal-title":"J Autoimmun"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e171844","DOI":"10.1172\/jci.insight.171844","article-title":"GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes","volume":"9","author":"Uenishi","year":"2024","journal-title":"JCI Insight"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1463971","DOI":"10.3389\/fimmu.2024.1463971","article-title":"Regulatory CD4(+) T cells redirected against pathogenic CD8(+) T cells protect NOD mice from development of autoimmune diabetes","volume":"15","author":"Kakabadse","year":"2024","journal-title":"Front Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"114994","DOI":"10.1016\/j.celrep.2024.114994","article-title":"Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells","volume":"43","author":"Barra","year":"2024","journal-title":"Cell Rep"},{"key":"B178","doi-asserted-by":"publisher","first-page":"20417314251373039","DOI":"10.1177\/20417314251373039","article-title":"Gene editing strategies to address current challenges in stem cell-derived \u03b2 cell therapy for type 1 diabetes","volume":"16","author":"Han","year":"2025","journal-title":"J Tissue Eng."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1080\/1061186X.2025.2522869","article-title":"Emerging role of gene therapy in immune modulation and beta-cell preservation in type 1 diabetes","volume":"33","author":"Mittal","year":"2025","journal-title":"J Drug Target"},{"key":"B180","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/ijms27020794","article-title":"Constitutively active Stat5b expression in dendritic cells enhances treg-mediated elimination of autoreactive CD8(+) T cells in autoimmune diabetes","volume":"27","author":"Khongorzul","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B181","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2337\/dc20-0567","article-title":"Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications","volume":"44","author":"Jeyam","year":"2021","journal-title":"Diabetes Care"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e230503","DOI":"10.20945\/2359-4292-2023-0503","article-title":"Metabolic impact of residual C-peptide secretion in type 1 diabetes mellitus","volume":"68","author":"Lopes","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"B183","doi-asserted-by":"publisher","first-page":"112006","DOI":"10.1016\/j.diabres.2025.112006","article-title":"Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes","volume":"221","author":"Amendolara","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e002288","DOI":"10.1136\/bmjdrc-2021-002288","article-title":"Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes","volume":"9","author":"Wellens","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B185","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.celrep.2025.116174","article-title":"Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis","volume":"44","author":"Huber","year":"2025","journal-title":"Cell Rep"},{"key":"B186","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2337\/db25-0326","article-title":"Loss of insulin-positive cell clusters precedes the decrease in islet frequency and \u03b2-cell area in type 1 diabetes","volume":"74","author":"Drotar","year":"2025","journal-title":"Diabetes"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/db24-0008","article-title":"Regulation of STAT1 signaling in human pancreatic \u03b2-cells by the lysine deacetylase HDAC6: a new therapeutic opportunity in type 1 diabetes?","volume":"73","author":"Leslie","year":"2024","journal-title":"Diabetes"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1393248","DOI":"10.3389\/fimmu.2024.1393248","article-title":"Extracellular vesicles derived from stressed beta cells mediate monocyte activation and contribute to islet inflammation","volume":"15","author":"Dekkers","year":"2024","journal-title":"Front Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmet.2023.11.011","article-title":"Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes","volume":"36","author":"Knebel","year":"2024","journal-title":"Cell Metab"},{"key":"B190","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41419-024-06701-x","article-title":"Bax Inhibitor-1 preserves pancreatic \u03b2-cell proteostasis by limiting proinsulin misfolding and programmed cell death","volume":"15","author":"Blanc","year":"2024","journal-title":"Cell Death Dis"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00125-025-06426-2","article-title":"Exercise-induced meteorin-like protein protects human pancreatic beta cells from cytokine-induced apoptosis","volume":"68","author":"Costa-Junior","year":"2025","journal-title":"Diabetologia"},{"key":"B192","doi-asserted-by":"publisher","first-page":"e70134","DOI":"10.1002\/ctm2.70134","article-title":"LRH-1\/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype","volume":"14","author":"Cobo-Vuilleumier","year":"2024","journal-title":"Clin Transl Med"},{"key":"B193","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-025-08059-0","article-title":"IL-1\u03b2 priming triggers an adaptive stress response that enhances pancreatic \u03b2-cell resilience to subsequent cytotoxic inflammatory insult","volume":"16","author":"S\u00e9tula","year":"2025","journal-title":"Cell Death Dis"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/cells13131108","article-title":"Bromodomain protein inhibition protects \u03b2-cells from cytokine-induced death and dysfunction via antagonism of NF-\u03baB pathway","volume":"13","author":"Negi","year":"2024","journal-title":"Cells"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00125-024-06193-6","article-title":"Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans","volume":"67","author":"Wreven","year":"2024","journal-title":"Diabetologia"},{"key":"B196","doi-asserted-by":"publisher","first-page":"e14267","DOI":"10.1111\/apha.14267","article-title":"DECORIN, a triceps-derived myokine, protects sorted \u03b2-cells and human islets against chronic inflammation associated with type 2 diabetes","volume":"241","author":"Langlois","year":"2025","journal-title":"Acta Physiol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jama.2023.2140","article-title":"Effect of tight glycemic control on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial","volume":"329","author":"McVean","year":"2023","journal-title":"JAMA"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41591-024-03463-z","article-title":"Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial","volume":"31","author":"Pasqua","year":"2025","journal-title":"Nat Med"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1111\/dom.15458","article-title":"Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: results from the multicentre, open-label, prospective study","volume":"26","author":"Nakamura","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B200","doi-asserted-by":"publisher","first-page":"zqae015","DOI":"10.1093\/function\/zqae015","article-title":"Single cell RNAseq analysis of cytokine-treated human islets: association of cellular stress with impaired cytokine responsiveness","volume":"5","author":"Stancill","year":"2024","journal-title":"Function"},{"key":"B201","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.cmet.2024.09.006","article-title":"Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights","volume":"36","author":"Sokolowski","year":"2024","journal-title":"Cell Metab"},{"key":"B202","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12933-025-02696-7","article-title":"Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis","volume":"24","author":"Wu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","article-title":"Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates","volume":"28","author":"Du","year":"2022","journal-title":"Nat Med"},{"key":"B204","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","article-title":"Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"B205","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem cell-derived, fully differentiated islets for type 1 diabetes","volume":"393","author":"Reichman","year":"2025","journal-title":"N Engl J Med"},{"key":"B206","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1097\/TP.0000000000004180","article-title":"Outcomes following extrahepatic and intraportal pancreatic islet transplantation: a comparative cohort study","volume":"106","author":"Verhoeff","year":"2022","journal-title":"Transplantation"},{"key":"B207","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2337\/figshare.21120631","article-title":"Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the clinical islet transplantation consortium: the CIT-08 study","volume":"45","author":"Rickels","year":"2022","journal-title":"Diabetes Care"},{"key":"B209","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/01.tp.0000994628.94091.b6","article-title":"Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the collaborative islet transplant registry","volume":"11","author":"Chetboun","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/SLA.0000000000005783","article-title":"Pancreas and islet transplantation: comparative outcome analysis of a single-centre cohort over 20-years","volume":"277","author":"Marfil-Garza","year":"2023","journal-title":"Ann Surg"},{"key":"B211","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.xcrm.2021.100466","article-title":"Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device","volume":"2","author":"Shapiro","year":"2021","journal-title":"Cell Rep Med"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1391504","DOI":"10.3389\/fimmu.2024.1391504","article-title":"Pancreatic islet transplantation: current advances and challenges","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3390\/cells13211783","article-title":"Islet transplantation: current limitations and challenges for successful outcomes","volume":"13","author":"Langlois","year":"2024","journal-title":"Cells"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1293762","DOI":"10.3389\/fimmu.2023.1293762","article-title":"Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1715863","DOI":"10.3389\/fimmu.2026.1715863","article-title":"Modulating immune response for the prevention and treatment of type 1 diabetes","volume":"17","author":"Vohidova","year":"2026","journal-title":"Front Immunol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","article-title":"Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells","volume":"40","author":"Balboa","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/7651_2020_323","article-title":"Highly efficient differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX61 methods","volume":"2454","author":"Memon","year":"2022","journal-title":"Mol Biol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40824-023-00419-1","article-title":"Self-organized insulin-producing \u03b2-cells differentiated from human omentum-derived stem cells and their in vivo therapeutic potential","volume":"27","author":"Jeong","year":"2023","journal-title":"Biomater Res"},{"key":"B219","doi-asserted-by":"publisher","first-page":"e19972","DOI":"10.1016\/j.heliyon.2023.e19972","article-title":"The functional maturity of grafted human pluripotent stem cell derived-islets (hSC-Islets) evaluated by the glycemic set point during blood glucose normalizing process in diabetic mice","volume":"9","author":"Yabe","year":"2023","journal-title":"Heliyon"},{"key":"B220","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s12276-024-01380-2","article-title":"SPOCK2 controls the proliferation and function of immature pancreatic \u03b2-cells through MMP2","volume":"57","author":"Blaszczyk","year":"2025","journal-title":"Exp Mol Med"},{"key":"B221","doi-asserted-by":"publisher","first-page":"015034","DOI":"10.1088\/1758-5090\/ad998e","article-title":"Engineering pore-enriched and pre-vascularized volumetric constructs for enhanced blood glucose regulation in type 1 diabetes therapy","volume":"17","author":"Kim","year":"2024","journal-title":"Biofabrication"},{"key":"B222","doi-asserted-by":"publisher","first-page":"9636897241288932","DOI":"10.1177\/09636897241288932","article-title":"Xenogenic engraftment of human-induced pluripotent stem cell-derived pancreatic islet cells in an immunosuppressive diabetic g\u00f6ttingen mini-pig model","volume":"33","author":"Yamasaki","year":"2024","journal-title":"Cell Transplant"},{"key":"B223","doi-asserted-by":"publisher","first-page":"109538","DOI":"10.1016\/j.celrep.2021.109538","article-title":"Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection","volume":"36","author":"Parent","year":"2021","journal-title":"Cell Rep"},{"key":"B224","doi-asserted-by":"publisher","first-page":"100879","DOI":"10.1016\/j.xcrm.2022.100879","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","author":"Gerace","year":"2023","journal-title":"Cell Rep Med"},{"key":"B225","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"B226","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s13287-025-04745-0","article-title":"Engineering hypoimmune stem cell-derived beta cells","volume":"16","author":"Licht","year":"2025","journal-title":"Stem Cell Res Ther."},{"key":"B227","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1038\/s41467-024-47972-4","article-title":"Acinar to \u03b2-like cell conversion through inhibition of focal adhesion kinase","volume":"15","author":"Dahiya","year":"2024","journal-title":"Nat Commun"},{"key":"B228","doi-asserted-by":"publisher","first-page":"102050","DOI":"10.1016\/j.molmet.2024.102050","article-title":"Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners","volume":"90","author":"Coate","year":"2024","journal-title":"Mol Metab"},{"key":"B229","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s42255-020-0212-y","article-title":"An artificial intelligence decision support system for the management of type 1 diabetes","volume":"2","author":"Tyler","year":"2020","journal-title":"Nat Metab"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1644907","DOI":"10.3389\/fphar.2025.1644907","article-title":"Exploring the potential of computer simulation models in drug testing and biomedical research: a systematic review","volume":"16","author":"Mittal","year":"2025","journal-title":"Front Pharmacol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"110029","DOI":"10.1016\/j.diabres.2022.110029","article-title":"Predicting misdiagnosed adult-onset type 1 diabetes using machine learning","volume":"191","author":"Cheheltani","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B232","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/biomedicines12030492","article-title":"Supervised parametric learning in the identification of composite biomarker signatures of type 1 diabetes in integrated parallel multi-omics datasets","volume":"12","author":"Bonnell","year":"2024","journal-title":"Biomedicines"},{"key":"B233","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/biom11030383","article-title":"Parallel multi-omics in high-risk subjects for the identification of integrated biomarker signatures of type 1 diabetes","volume":"11","author":"Alcazar","year":"2021","journal-title":"Biomolecules"},{"key":"B234","doi-asserted-by":"publisher","first-page":"20420188251337988","DOI":"10.1177\/20420188251337988","article-title":"Multi-omics investigation of prospective therapeutic targets for type 1 diabetes","volume":"16","author":"Zhang","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B235","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00125-024-06246-w","article-title":"Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis","volume":"67","author":"You","year":"2024","journal-title":"Diabetologia"},{"key":"B236","doi-asserted-by":"publisher","first-page":"20798","DOI":"10.1038\/s41598-024-71717-4","article-title":"Plasma proteomics in children with new-onset type 1 diabetes identifies new potential biomarkers of partial remission","volume":"14","author":"Poll\u00e9","year":"2024","journal-title":"Sci Rep"},{"key":"B237","doi-asserted-by":"publisher","first-page":"eadw8946","DOI":"10.1126\/sciadv.adw8946","article-title":"Longitudinal monitoring of type 1 diabetes progression to disease onset","volume":"12","author":"King","year":"2026","journal-title":"Sci Adv"},{"key":"B238","doi-asserted-by":"publisher","first-page":"e3093","DOI":"10.1210\/clinem\/dgae863","article-title":"Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes","volume":"110","author":"Yoshimura","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B239","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12916-024-03476-y","article-title":"First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers","volume":"22","author":"Van Rampelbergh","year":"2024","journal-title":"BMC Med"},{"key":"B240","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1111\/dom.16373","article-title":"Two-pronged approach: therapeutic effect of biological scaffold combined with immune intervention and \u03b2-cell replacement on type 1 diabetic mice","volume":"27","author":"Dai","year":"2025","journal-title":"Diabetes Obes Metab."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2337\/figshare.25872457","article-title":"Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles","volume":"47","author":"Ghalwash","year":"2024","journal-title":"Diabetes Care"},{"key":"B242","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1161\/STROKEAHA.124.046125","article-title":"Adaptive clinical trials in stroke","volume":"55","author":"Crawford","year":"2024","journal-title":"Stroke"},{"key":"B243","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/PCC.0000000000003273","article-title":"Adaptive clinical trials in pediatric critical care: a systematic review","volume":"24","author":"Gilholm","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"B244","doi-asserted-by":"publisher","first-page":"150935","DOI":"10.1016\/j.tmrv.2025.150935","article-title":"A practical review of adaptive platform trials","volume":"39","author":"Angeloni","year":"2025","journal-title":"Transfus Med Rev."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/biom.13694","article-title":"A Bayesian platform trial design to simultaneously evaluate multiple drugs in multiple indications with mixed endpoints","volume":"79","author":"Zhao","year":"2023","journal-title":"Biometrics"},{"key":"B246","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/ijerph18020530","article-title":"The bayesian design of adaptive clinical trials","volume":"18","author":"Giovagnoli","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B247","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cct.2017.01.003","article-title":"Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials","volume":"54","author":"Lin","year":"2017","journal-title":"Contemp Clin Trials."},{"key":"B248","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"B249","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.euf.2023.10.016","article-title":"How to compose platform trials","volume":"9","author":"Clarke","year":"2023","journal-title":"Eur Urol Focus."},{"key":"B250","doi-asserted-by":"publisher","first-page":"e060664","DOI":"10.1136\/bmjopen-2021-060664","article-title":"I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations","volume":"12","author":"Files","year":"2022","journal-title":"BMJ Open"},{"key":"B251","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.therap.2022.12.003","article-title":"Platform trials","volume":"78","author":"Roustit","year":"2023","journal-title":"Therapie."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.04.025","article-title":"An overview of platform trials with a checklist for clinical readers","volume":"125","author":"Park","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2023.02.010","article-title":"Methodology and design of platform trials: a meta-epidemiological study","volume":"157","author":"Pitre","year":"2023"},{"key":"B254","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bja.2022.10.030","article-title":"Platform trials for anaesthesia and perioperative medicine: a narrative review","volume":"130","author":"Myles","year":"2023","journal-title":"Br J Anaesth"},{"key":"B255","doi-asserted-by":"publisher","first-page":"e243109","DOI":"10.1001\/jamanetworkopen.2024.3109","article-title":"Characteristics, progression, and output of randomized platform trials: a systematic review","volume":"7","author":"Griessbach","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B256","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/17407745221112001","article-title":"Analysis of adaptive platform trials using a network approach","volume":"19","author":"Marschner","year":"2022","journal-title":"Clin Trials."},{"key":"B257","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/psp4.13193","article-title":"Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development tool CPT Pharmacometrics","volume":"13","author":"Morales","year":"2024","journal-title":"Syst Pharmacol"},{"key":"B258","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2337\/db25-0310","article-title":"Novel approach for assessing outcomes of type 1 diabetes prevention trials over a fixed time interval","volume":"74","author":"Sims","year":"2025","journal-title":"Diabetes"},{"key":"B259","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S2213-8587(23)00267-X","article-title":"C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis","volume":"11","author":"Taylor","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B260","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12916-023-02900-z","article-title":"First-in-human, double-blind, randomized phase 1B study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes","volume":"21","author":"Van Rampelbergh","year":"2023","journal-title":"BMC Med"},{"key":"B261","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00125-023-06014-2","article-title":"A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab","volume":"67","author":"Mathieu","year":"2024","journal-title":"Diabetologia"},{"key":"B262","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00125-024-06290-6","article-title":"Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial","volume":"68","author":"Hostrup","year":"2025","journal-title":"Diabetologia."},{"key":"B263","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2337\/dc22-1721","article-title":"Examining the acute glycemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting: the type 1 diabetes and exercise initiative (T1DEXI)","volume":"46","author":"Riddell","year":"2023","journal-title":"Diabetes Care"},{"key":"B264","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1111\/dom.15254","article-title":"Interrupting prolonged sitting with frequent short bouts of light-intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: the SIT-LESS randomised controlled trial","volume":"25","author":"Campbell","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B265","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/dia.2022.0338","article-title":"A randomized crossover pilot study evaluating glucose control during exercise initiated 1 or 2 h after a meal in adults with type 1 diabetes treated with an automated insulin delivery system","volume":"25","author":"Myette-C\u00f4t\u00e9","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"B266","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.2337\/dc24-0898","article-title":"Management of prolonged aerobic exercise in people with type 1 diabetes on automated insulin delivery systems: a randomized controlled study","volume":"47","author":"Corrado","year":"2024","journal-title":"Diabetes Care"},{"key":"B267","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00125-023-06051-x","article-title":"High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study","volume":"67","author":"Farrell","year":"2024","journal-title":"Diabetologia"},{"key":"B268","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A randomized trial of closed-loop control in children with type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N Engl J Med"},{"key":"B269","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa2111673","article-title":"Randomized trial of closed-loop control in very young children with type 1 diabetes","volume":"386","author":"Ware","year":"2022","journal-title":"N Engl J Med"},{"key":"B270","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa2210834","article-title":"Trial of hybrid closed-loop control in young children with type 1 diabetes","volume":"388","author":"Wadwa","year":"2023","journal-title":"N Engl J Med"},{"key":"B271","doi-asserted-by":"publisher","first-page":"EVIDoa2400185","DOI":"10.1056\/EVIDoa2400185","article-title":"Automated insulin delivery for young people with type 1 diabetes and elevated A1c","volume":"3","author":"Boucsein","year":"2024","journal-title":"NEJM Evid"},{"key":"B272","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2337\/dc22-0525","article-title":"Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: a multicenter randomized clinical trial","volume":"46","author":"Gomez-Peralta","year":"2023","journal-title":"Diabetes Care"},{"key":"B273","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/dia.2022.0562","article-title":"First use of open-source automated insulin delivery androidaps in full closed-loop scenario: pancreas4ALL randomized pilot study","volume":"25","author":"Petruzelkova","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"B274","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s44324-025-00089-8","article-title":"A deep learning-derived digital biomarker of dysglycemia and its association with genetic risk of type 2 diabetes","volume":"3","author":"Shao","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"B275","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S2213-8587(25)00364-X","article-title":"Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA(1c) (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial","volume":"14","author":"Wilmot","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B276","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.2337\/dc24-0838","article-title":"A randomized comparison of postprandial glucose excursion using inhaled insulin versus rapid-acting analog insulin in adults with type 1 diabetes using multiple daily injections of insulin or automated insulin delivery","volume":"47","author":"Hirsch","year":"2024","journal-title":"Diabetes Care"},{"key":"B277","doi-asserted-by":"publisher","first-page":"108385","DOI":"10.1016\/j.jdiacomp.2022.108385","article-title":"Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting","volume":"37","author":"Oriot","year":"2023","journal-title":"J Diabetes Complications."},{"key":"B278","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S2213-8587(25)00091-9","article-title":"Efficacy and safety of automated insulin delivery in children aged 2-6 years (LENNY): an open-label, multicentre, randomised, crossover trial","volume":"13","author":"Battelino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B279","doi-asserted-by":"publisher","first-page":"33662","DOI":"10.1038\/s41598-025-18119-2","article-title":"Glucodensity functional profiles outperform traditional continuous glucose monitoring metrics","volume":"15","author":"Matabuena","year":"2025","journal-title":"Sci Rep"},{"key":"B280","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/dia.2023.0139","article-title":"Unannounced meal challenges using an advanced hybrid closed-loop system","volume":"25","author":"Shalit","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"B281","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/dc22-0470","article-title":"Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to minimed 780G advanced hybrid closed-loop system: a two-center, randomized, controlled study","volume":"45","author":"Matejko","year":"2022","journal-title":"Diabetes Care"},{"key":"B282","doi-asserted-by":"publisher","first-page":"6906023","DOI":"10.1155\/2023\/6906023","article-title":"Adolescent- and young adult-reported outcomes and use of continuous glucose monitoring features: a report from the CITY trial","volume":"2023","author":"Messer","year":"2023","journal-title":"Pediatr Diabetes"},{"key":"B283","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B284","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2213-8587(22)00352-7","article-title":"Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial","volume":"11","author":"Visser","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B285","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.2337\/dc25-0407","article-title":"Evaluation of a prediction-based bedtime intervention in reducing nocturnal low glucose in adults with type 1 diabetes: the dailydose bedtime smart snack crossover study","volume":"48","author":"Mosquera-Lopez","year":"2025","journal-title":"Diabetes Care."},{"key":"B286","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0140-6736(21)00789-3","article-title":"Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial","volume":"397","author":"Visser","year":"2021","journal-title":"Lancet"},{"key":"B287","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00125-024-06155-y","article-title":"Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial","volume":"67","author":"Kim","year":"2024","journal-title":"Diabetologia"},{"key":"B288","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1111\/dme.70119","article-title":"Effect of switching from intermittently scanned to real-time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: a real-world, Canadian retrospective study","volume":"42","author":"Chu","year":"2025","journal-title":"Diabet Med."},{"key":"B289","doi-asserted-by":"publisher","first-page":"e60190","DOI":"10.2196\/60190","article-title":"Beyond hemoglobin A1c-outcomes that matter to individuals with type 1 diabetes in adopting digital health interventions for self-management support: qualitative study","volume":"9","author":"Markowitz","year":"2024","journal-title":"JMIR Diabetes"},{"key":"B290","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/15209156251380860","article-title":"Decision support tool for self-management of insulin dosing in type 1 diabetes with multiple daily injections: a proof-of-concept study","volume":"28","author":"Nimri","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"B291","doi-asserted-by":"publisher","first-page":"7261998","DOI":"10.1155\/pedi\/7261998","article-title":"Effect of an intensive, integrated telehealth intervention on glycemic control in children and adolescents with type 1 diabetes using continuous glucose monitoring: a randomized, crossover trial","volume":"2025","author":"Deeb","year":"2025","journal-title":"Pediatr Diabetes"},{"key":"B292","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00125-026-06713-6","article-title":"The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover comparison","volume":"69","author":"McClure","year":"2026","journal-title":"Diabetologia"},{"key":"B293","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13340-023-00683-5","article-title":"Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study","volume":"15","author":"ISCHIA Study","year":"2024","journal-title":"Diabetol Int"},{"key":"B294","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00125-026-06674-w","article-title":"Analysis of glycaemic control and treatment satisfaction with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial","volume":"69","author":"Sebastian-Valles","year":"2026","journal-title":"Diabetologia"},{"key":"B295","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/dia.2023.0508","article-title":"Clinical outcomes with minimed(TM) 780G advanced hybrid closed-loop therapy in 2- to 6-year-old children with type 1 diabetes","volume":"26","author":"Abraham","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"B296","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/15209156261423558","article-title":"Glycemic outcomes during outpatient use of automated insulin delivery without meal announcement in adults with type 1 diabetes: results from the CLOSE IT randomized controlled trial","volume":"28","author":"Wilkinson","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"B297","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1177\/19322968241236208","article-title":"A machine learning model for week-ahead hypoglycemia prediction from continuous glucose monitoring data","volume":"19","author":"Giammarino","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"B298","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41591-020-1045-7","article-title":"Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes","volume":"26","author":"Nimri","year":"2020","journal-title":"Nat Med"},{"key":"B299","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1109\/TBME.2022.3187703","article-title":"Personalized blood glucose prediction for type 1 diabetes using evidential deep learning and meta-learning","volume":"70","author":"Zhu","year":"2023","journal-title":"IEEE Trans Biomed Eng"},{"key":"B300","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1932296820965561","article-title":"Adjustment of insulin pump settings in type 1 diabetes management: advisor pro device compared to physicians' recommendations","volume":"16","author":"Nimri","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B301","doi-asserted-by":"publisher","first-page":"39738","DOI":"10.1038\/s41598-025-23165-x","article-title":"A digital twin-enhanced decision support system improves time-in-range in type 1 diabetes: a randomized clinical trial","volume":"15","author":"Builes-Monta\u00f1o","year":"2025","journal-title":"Sci Rep"},{"key":"B302","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1177\/19322968221092785","article-title":"Long-term prediction of blood glucose levels in type 1 diabetes using a CNN-LSTM-based deep neural network","volume":"17","author":"Jaloli","year":"2023","journal-title":"J Diabetes Sci Technol."},{"key":"B303","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1109\/TBME.2025.3635264","article-title":"Data augmentation via digital twins to develop personalized deep learning glucose prediction algorithms for type 1 diabetes in poor data context","volume":"73","author":"Prendin","year":"2026","journal-title":"IEEE Trans Biomed Eng."},{"key":"B304","doi-asserted-by":"publisher","first-page":"15209156261432144","DOI":"10.1177\/15209156261432144","article-title":"Glucose predictions improve glycemic control: a digital twin evaluation","volume":"2026","author":"Herrero","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"B305","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/dia.2023.0531","article-title":"Development of machine learning models for the identification of elevated ketone bodies during hyperglycemia in patients with type 1 diabetes","volume":"26","author":"Lebech Cichosz","year":"2024","journal-title":"Diabetes Technol Ther."},{"key":"B306","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/dia.2024.0484","article-title":"Predicting and ranking diabetic ketoacidosis risk among youth with type 1 diabetes with a clinic-to-clinic transferrable machine learning model","volume":"27","author":"Vandervelden","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B307","doi-asserted-by":"publisher","first-page":"e112819","DOI":"10.1136\/bmjopen-2025-112819","article-title":"Prospective validation of an AI algorithm to identify adult-onset type 1 diabetes misclassification: protocol for a non-interventional multicentre study","volume":"16","author":"Brusini","year":"2026","journal-title":"BMJ Open"},{"key":"B308","doi-asserted-by":"publisher","first-page":"ooaf133","DOI":"10.1093\/jamiaopen\/ooaf133","article-title":"Deploying machine learning models in clinical settings: a real-world feasibility analysis for a model identifying adult-onset type 1 diabetes initially classified as type 2","volume":"8","author":"Brusini","year":"2025","journal-title":"JAMIA Open"},{"key":"B309","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2337\/dc25-1526","article-title":"Safety and feasibility of a fully automated insulin delivery system: FCL@Home, a multicenter randomized clinical trial in individuals with type 1 diabetes","volume":"49","author":"Moscoso-Vasquez","year":"2026","journal-title":"Diabetes Care"},{"key":"B310","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.2337\/dc22-2297","article-title":"A randomized crossover trial to compare automated insulin delivery (the artificial pancreas) with carbohydrate counting or simplified qualitative meal-size estimation in type 1 diabetes","volume":"46","author":"Haidar","year":"2023","journal-title":"Diabetes Care"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.2337\/figshare.14999709","article-title":"Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal","author":"Garcia-Tirado","year":"2021","journal-title":"Diabetes Care"},{"key":"B312","doi-asserted-by":"publisher","first-page":"15209156261456440","DOI":"10.1177\/15209156261456440","article-title":"Comparing automated lyumjev\u00ae delivery with carbohydrate counting, qualitative meal-size estimation, and fully closed-loop in type 1 diabetes: a pilot, randomized, crossover trial","volume":"2026","author":"Schumacher","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"B313","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/19322968241292369","article-title":"Prediction of incident diabetic retinopathy in adults with type 1 diabetes using machine learning approach: an exploratory study","volume":"20","author":"Montaser","year":"2026","journal-title":"J Diabetes Sci Technol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/dia.2023.0486","article-title":"Time in range is associated with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study","volume":"26","author":"Shah","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"B315","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1507\/endocrj.EJ22-0178","article-title":"Characteristic gene prognostic model of type 1 diabetes mellitus via machine learning strategy","volume":"70","author":"Wang","year":"2023","journal-title":"Endocr J"},{"key":"B316","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00125-022-05778-3","article-title":"Precision medicine in type 1 diabetes","volume":"65","author":"Carr","year":"2022","journal-title":"Diabetologia."},{"key":"B317","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jare.2023.11.025","article-title":"Machine learning approach reveals microbiome, metabolome, and lipidome profiles in type 1 diabetes","volume":"64","author":"Tan","year":"2024","journal-title":"J Adv Res"},{"key":"B318","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.artmed.2019.07.007","article-title":"Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes","volume":"98","author":"Woldaregay","year":"2019","journal-title":"Artif Intell Med"},{"key":"B319","doi-asserted-by":"publisher","first-page":"e11030","DOI":"10.2196\/11030","article-title":"Data-driven blood glucose pattern classification and anomalies detection: machine-learning applications in type 1 diabetes","volume":"21","author":"Woldaregay","year":"2019","journal-title":"J Med Internet Res"},{"key":"B320","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.3390\/jcm14165621","article-title":"Historically based perspective on the immunotherapy of type 1 diabetes: where we have been, where we are, and where we may go","volume":"14","author":"Cavalli","year":"2025","journal-title":"J Clin Med"},{"key":"B321","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00125-024-06339-6","article-title":"Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes","volume":"68","author":"Shapiro","year":"2025","journal-title":"Diabetologia"},{"key":"B322","doi-asserted-by":"publisher","first-page":"1478139","DOI":"10.3389\/fendo.2025.1478139","article-title":"Identification and validation of endoplasmic reticulum stress-related diagnostic biomarkers for type 1 diabetic cardiomyopathy based on bioinformatics and machine learning","volume":"16","author":"Tang","year":"2025","journal-title":"Front Endocrinol"},{"key":"B323","doi-asserted-by":"publisher","first-page":"1543806","DOI":"10.3389\/fonc.2025.1543806","article-title":"Integrating machine learning and single-cell sequencing to identify shared biomarkers in type 1 diabetes mellitus and clear cell renal cell carcinoma","volume":"15","author":"Li","year":"2025","journal-title":"Front Oncol"},{"key":"B324","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-genom-021623-104458","article-title":"Somatic gene therapy: ethics and access","volume":"25","author":"Bateman-House","year":"2024","journal-title":"Annu Rev Genomics Hum Genet."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1915502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:56:20Z","timestamp":1790240180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1915502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":324,"alternative-id":["10.3389\/fpubh.2026.1915502"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1915502","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1915502"}}